ArticleBMC cancer2021

Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer.

Qi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.